F-actin and myosin F control apicoplast elongation dynamics which drive apicoplast-centrosome association in Toxoplasma gondii
mBio · 2023
DOI: 10.1128/mbio.01640-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Parvathi Madhavi Devarakonda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of Connecticut , Storrs, Connecticut, USA. Hauptthemen laut MEDLINE: Apicoplasts, Toxoplasma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences.
Abstract (Originalsprache)
Toxoplasma gondii contains an essential plastid organelle called the apicoplast that is necessary for fatty acid, isoprenoid, and heme synthesis. Perturbations affecting apicoplast function or inheritance lead to parasite death. The apicoplast is a single copy organelle and, therefore, must be divided so that each daughter parasite inherits an apicoplast during cell division. In this study, we identify new roles for F-actin and an unconventional myosin motor, TgMyoF, in this process. First, loss of TgMyoF and actin lead to an accumulation of apicoplast vesicles in the cytosol indicating a role for this actomyosin system in apicoplast protein trafficking or morphological integrity of the organelle. Second, live cell imaging reveals that during division the apicoplast is highly dynamic, exhibiting branched, U-shaped and linear morphologies that are dependent on TgMyoF and actin. In parasites where movement was inhibited by the depletion of TgMyoF, the apicoplast fails to associate with the parasite centrosomes. Thus, this study provides crucial new insight into mechanisms controlling apicoplast-centrosome association, a vital step in the apicoplast division cycle, which ensures that each daughter inherits a single apicoplast. IMPORTANCE Toxoplasma gondii and most other parasites in the phylum Apicomplexa contain an apicoplast, a non-photosynthetic plastid organelle required for fatty acid, isoprenoid, iron-sulfur cluster, and heme synthesis. Perturbation of apicoplast function results in parasite death. Thus, parasite survival critically depends on two cellular processes: apicoplast division to ensure every daughter parasite inherits a single apicoplast, and trafficking of nuclear encoded proteins to the apicoplast. Despite the importance of these processes, there are significant knowledge gaps in regards to the molecular mechanisms which control these processes; this is particularly true for trafficking of nuclear-encoded apicoplast proteins. This study provides crucial new insight into the timing of apicoplast protein synthesis and trafficking to the apicoplast. In addition, this study demonstrates how apicoplast-centrosome association, a key step in the apicoplast division cycle, is controlled by the actomyosin cytoskeleton.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of Connecticut , Storrs, Connecticut, USA.
ORCID-Profile: Aoife T Heaslip
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Devarakonda, P. M., Sarmiento, V., & Heaslip, A. T. (2023). F-actin and myosin F control apicoplast elongation dynamics which drive apicoplast-centrosome association in Toxoplasma gondii. mBio. https://doi.org/10.1128/mbio.01640-23
Vancouver
Devarakonda PM, Sarmiento V, Heaslip AT. F-actin and myosin F control apicoplast elongation dynamics which drive apicoplast-centrosome association in Toxoplasma gondii. mBio. 2023. doi:10.1128/mbio.01640-23
BibTeX
@article{Devarakonda2023,
author = {Devarakonda, Parvathi Madhavi and Sarmiento, Valeria and Heaslip, Aoife T},
title = {F-actin and myosin F control apicoplast elongation dynamics which drive apicoplast-centrosome association in Toxoplasma gondii},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.01640-23}
}
EUVIMED